{
      "id_number": "oai:ojs.pkp.sfu.ca:article/6839",
      "full_text_status": "none",
      "type": "article",
      "date": "2026-02-14",
      "uri": "https://arxiv.universalpublishings.com/id/eprint/65731",
      "note": "Imported from MJST Journal (OAI id oai:ojs.pkp.sfu.ca:article/6839)",
      "metadata_visibility": "show",
      "date_type": "published",
      "ispublished": "pub",
      "official_url": "https://mjstjournal.com/index.php/mjst/article/view/6839",
      "subjects": [
        "Alzheimer\u2019s disease; mild cognitive impairment (MCI); early diagnosis; cognitive screening; functional assessment; biomarkers; AT(N); MRI/CT; PET; blood-based biomarkers."
      ],
      "userid": 1,
      "publisher": "Center for Tech and Media Research",
      "rev_number": 1,
      "datestamp": "2026-05-26 15:55:51",
      "eprintid": 65731,
      "creators": [
        {
          "name": {
            "given": "Choriyev",
            "honourific": null,
            "family": "Shohjahon",
            "lineage": null
          }
        },
        {
          "name": {
            "honourific": null,
            "given": "Alimova",
            "family": "Zebiniso",
            "lineage": null
          }
        }
      ],
      "abstract": "Alzheimer\u2019s disease (AD) is the most common cause of dementia and is characterized by progressive cognitive decline. Early identification of AD is essential to stage the disease, assess risk, and prepare an advance care plan for the patient and family. This review discusses clinical and biological notions of \u201cearly\u201d AD, and summarizes a stepwise diagnostic pathway: clinical evaluation, brief cognitive screening, functional assessment, exclusion of reversible causes, structural neuroimaging, and targeted use of biomarkers (CSF, PET, and blood-based markers). The recent expansion of blood-based biomarkers can make early diagnosis more accessible, but these tests must not be used as stand\u2011alone screening or diagnostic tools; results require interpretation within the clinical context.",
      "title": "EARLY DIAGNOSIS OF COGNITIVE IMPAIRMENT IN ALZHEIMER\u2019S DISEASE",
      "status_changed": "2026-05-26 15:55:51",
      "eprint_status": "archive",
      "lastmod": "2026-05-26 15:55:51",
      "publication": "Multidisciplinary Journal of Science and Technology",
      "sword_depositor": 1,
      "dir": "disk0/00/06/57/31",
      "keywords": "Alzheimer\u2019s disease; mild cognitive impairment (MCI); early diagnosis; cognitive screening; functional assessment; biomarkers; AT(N); MRI/CT; PET; blood-based biomarkers."
    }